Literature DB >> 28668166

PET/MR Imaging in Gynecologic Oncology.

Michael A Ohliger1, Thomas A Hope2, Jocelyn S Chapman3, Lee-May Chen3, Spencer C Behr4, Liina Poder4.   

Abstract

MR imaging and PET using 2-Deoxy-2-[18F]fluoroglucose (FDG) are both useful in the evaluation of gynecologic malignancies. MR imaging is superior for local staging of disease whereas fludeoxyglucose FDG PET is superior for detecting distant metastases. Integrated PET/MR imaging scanners have great promise for gynecologic malignancies by combining the advantages of each modality into a single scan. This article reviews the technology behind PET/MR imaging acquisitions and technical challenges relevant to imaging the pelvis. A dedicated PET/MR imaging protocol; the roles of PET and MR imaging in cervical, endometrial, and ovarian cancers; and future directions for PET/MR imaging are discussed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Endometrial cancer; Gynecology; MR imaging; Ovarian cancer; PET; PET/MR imaging

Mesh：

Year:  2017        PMID： 28668166     DOI： 10.1016/j.mric.2017.03.012

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN： 1064-9689            Impact factor:   2.266


  5 in total

Review 1.  PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.

Authors:  Elizabeth A Sadowski; Ali Pirasteh; Alan B McMillan; Kathryn J Fowler; Joanna E Kusmirek
Journal:  Abdom Radiol (NY)       Date:  2021-10-23

Review 2.  Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.

Authors:  Mayur Virarkar; Dhakshinamoorthy Ganeshan; Anjalie Tara Gulati; Sarah Palmquist; Revathy Iyer; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11-11

Review 3.  Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.

Authors:  Richard L Wahl; Panithaya Chareonthaitawee; Bonnie Clarke; Alexander Drzezga; Liza Lindenberg; Arman Rahmim; James Thackeray; Gary A Ulaner; Wolfgang Weber; Katherine Zukotynski; John Sunderland
Journal:  J Nucl Med       Date:  2021-01       Impact factor: 11.082

Review 4.  Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging.

Authors:  Stefania Rizzo; Marco Femia; Valentina Buscarino; Dorella Franchi; Annalisa Garbi; Vanna Zanagnolo; Maria Del Grande; Lucia Manganaro; Sarah Alessi; Caterina Giannitto; Francesca Ruju; Massimo Bellomi
Journal:  Cancer Imaging       Date:  2018-12-04       Impact factor: 3.909

5.  Diagnostic value of integrated 18F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT.

Authors:  Yang Yu; Le Zhang; Bilkis Sultana; Bo Wang; Hongzan Sun
Journal:  BMC Cancer       Date:  2022-09-01       Impact factor: 4.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.